Gothenburg, Sweden-based Getinge designed the turbine-driven ventilator to offer ICU-quality ventilation. However, its non-invasive nature gears it more toward spontaneously breathing patients in need of extra breathing support.
The ventilator features a powerful turbine and long-lasting battery backup power. Getinge said in a news release that it can operate independent of wall gas with suitability for intrahospital transports.
Additionally, the system offers embedded workflows, support for High Flow therapy and a CO2 monitoring option. It features tools capable of supporting the escalation of therapy if necessary, too, Getinge said.
The company plans to make the product available for U.S. customers beginning in September 2023.
“We are happy to broaden our ventilator product offering for the U.S. market,” said Elin Frostehav, president of acute care therapies at Getinge. “This significantly increases our addressable ventilation market in the US, by now being able to target the non-invasive hospital segment with our ventilation offering.”